Arcadia Biosciences's total assets for Q2 2025 were $7.79M, a decrease of -40.05% from the previous quarter. RKDA total liabilities were $3.25M for the fiscal quarter, a -20.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.